20:21 , Aug 18, 2017 |  BioCentury  |  Finance

Close affiliation

A fresh investment in antibody manufacturing capacity in China will enable both Seattle-based Just Biotherapeutics Inc. and its affiliate Hangzhou Just Biotherapeutics Ltd. to scale up for late stage trials and commercial launches. The U.S....
16:08 , Aug 11, 2017 |  BC Week In Review  |  Financial News

Just China raises $57M series B

On Aug. 8, biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $57 million in a series B round led by Temasek. New investors Taikang, Hangzhou Economic & Technological Development Area, Bank of China and...
18:38 , Aug 8, 2017 |  BC Extra  |  Financial News

Just China raises $57M series B

Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $57 million in a series B round led by Temasek. New investors Taikang, Hangzhou Economic & Technological Development Area, Bank of China and Bank of Hangzhou...